Clinical Trial

Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous Angiosarcoma

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a pilot study evaluating the efficacy and safety of ivonescimab in subjects with advanced or metastatic cutaneous angiosarcoma who have previously been treated with taxane-based chemotherapy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-15.
Trial Details
NCT Number NCT07655570
Lead Sponsor M.D. Anderson Cancer Center
Conditions Cutaneous Angiosarcoma
Enrollment 10 participants
Start Date 2026-11-30
Primary Completion 2027-05-11 (estimated)
Study Completion 2029-05-11 (estimated)
Updated on ClinicalTrials.gov 2026-07-28